Halogenated acetates are produced in the disinfection of drinking water by chlorine, chloramine or ozone. In waters containing low bromide concentrations, chlorinated derivatives predominate. However, trace amounts of bromide in the water will result in a predominance of brominated analogs. Recent studies have shown that dichloroacetate (DCA) is a potent hepatotoxin and hepatocarcinogen in B6C3Fl mice and F344 rats. On the other hand, trichloroacetate (TCA) is a potent, but species specific hepatocarcinogen for mice and does not induce the hepatotoxic effects observed with DCA. Thus, there seems to be some ability to differentiate between processes that are involved in inducing hepatotoxic and hepatocarcinogenic effects of these compounds. Acutely, DCA is a more potent inducer of lipid peroxidation, whereas TCA appears more active chronically as a peroxisome proliferator. Pretreatments with DCA exacerbate the lipid peroxidation resulting from an acute dose of DCA, while pretreatment with TCA inhibits formation of thiobarbituric acid reactive substances (TBARS) following an acute dose of TCA. Pretreatment with another peroxisome proliferator, clofibrate, blocks TBARS formation following an acute dose of either DCA or TCA. These results are at odds with the greater accumulation of lipofuscin seen with chronic treatments with TCA in mice. The present project examines the relative ability of DCA, TCA and two monobrominated analogs, bromochloroacetate (BCA) and bromodichloroacetate (BDCA), to induce lipid peroxidation, peroxisome proliferation, 8-OH-guanine formation in hepatic DNA and RNA, cell proliferative responses and to protect against chemically-induced lipid peroxidation in mice, rats and guinea pigs. The studies will specifically examine how modification of cytochrome P450 and aldehyde dehydrogenase expression might account for the differing effects of these chemicals in mice (a susceptible species), rats (a selectively sensitive species) and guinea pigs (a species predicted to be non-susceptible to TCA and other peroxisome proliferators). These experiments should provide some important insights into how sensitive humans might be to these by-products of drinking water disinfection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES004648-04A1
Application #
3252763
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1988-09-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Washington State University
Department
Type
Schools of Pharmacy
DUNS #
041485301
City
Pullman
State
WA
Country
United States
Zip Code
99164
Kato-Weinstein, J; Stauber, A J; Orner, G A et al. (2001) Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice. J Appl Toxicol 21:81-9
Kato-Weinstein, J; Lingohr, M K; Orner, G A et al. (1998) Effects of dichloroacetate on glycogen metabolism in B6C3F1 mice. Toxicology 130:141-54
Austin, E W; Bull, R J (1997) Effect of pretreatment with dichloroacetate or trichloroacetate on the metabolism of bromodichloroacetate. J Toxicol Environ Health 52:367-83
Stauber, A J; Bull, R J (1997) Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol Appl Pharmacol 144:235-46
Parrish, J M; Austin, E W; Stevens, D K et al. (1996) Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 110:103-11
Austin, E W; Parrish, J M; Kinder, D H et al. (1996) Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam Appl Toxicol 31:77-82
Austin, E W; Okita, J R; Okita, R T et al. (1995) Modification of lipoperoxidative effects of dichloroacetate and trichloroacetate is associated with peroxisome proliferation. Toxicology 97:59-69
Bruschi, S A; Bull, R J (1993) In vitro cytotoxicity of mono-, di-, and trichloroacetate and its modulation by hepatic peroxisome proliferation. Fundam Appl Toxicol 21:366-75
Larson, J L; Bull, R J (1992) Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115:268-77
Bull, R J; Sanchez, I M; Nelson, M A et al. (1990) Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63:341-59

Showing the most recent 10 out of 12 publications